R
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
Ireland
Recent Filings
- 8-K189.7 KBRVL Pharmaceuticals plcFeb 13, 4:05 PM ET·0001104659-24-019866
- 8-K189.5 KBRVL Pharmaceuticals plcJan 17, 4:05 PM ET·0001104659-24-004463
- 8-K195.6 KBRVL Pharmaceuticals plcDec 20, 4:15 PM ET·0001104659-23-127735
- SC 13D/A132.7 KBRVL Pharmaceuticals plcNov 27, 9:24 PM ET·0001193125-23-283535
- 8-K51.7 MBRVL Pharmaceuticals plcNov 27, 4:06 PM ET·0001104659-23-121234
- 8-K194.8 KBRVL Pharmaceuticals plcNov 6, 4:05 PM ET·0001104659-23-114741
- SC 13D/A72.4 KBRVL Pharmaceuticals plcNov 1, 4:27 PM ET·0001171843-23-006596
- 8-K1.2 MBRVL Pharmaceuticals plcOct 20, 5:00 PM ET·0001104659-23-110536
- SC 13D/A129.7 KBRVL Pharmaceuticals plcOct 13, 5:28 PM ET·0001193125-23-256183
- 8-K744.7 KBRVL Pharmaceuticals plcOct 13, 4:15 PM ET·0001104659-23-109105
Insiders
10- Altchem Ltd10% Owner
- Avista Capital Partners III GP, L.P.10% Owner
- Avista Healthcare Partners GP, Ltd.10% Owner
- Avista Healthcare Partners, L.P.10% Owner
- Burgstahler David FDirector, 10% Owner
- COWAN GREGORY LDirector
- DeBiasi Michael J.Director
- DePetris MichaelPrincipal Accounting Officer
- deVries Tina MarieEVP, Research & Development
- Einhorn Andrew J.Chief Financial Officer
Tickers
No tickers on record
Addresses
business
400 CROSSING BOULEVARD
BRIDGEWATER, NJ, 08807
mailing
400 CROSSING BOULEVARD
BRIDGEWATER, NJ, 08807
Former Names
- Osmotica Pharmaceuticals plc2022-01-18
- Osmotica Pharmaceuticals Ltd2018-08-22